by Clinical Neuropsychologist | Wednesday, January 15, 2025 | Dementia
Abstract INTRODUCTION Deciphering the diverse molecular mechanisms in living Alzheimer’s disease (AD) patients is a big challenge but is pivotal for disease prognosis and precision medicine development. METHODS Utilizing an optimal transport approach, we...
by Clinical Neuropsychologist | Tuesday, January 14, 2025 | Dementia
Abstract INTRODUCTION Transcranial pulse stimulation (TPS) is increasingly being investigated as a promising potential treatment for Alzheimer’s disease (AD). Although the safety and preliminary clinical efficacy of TPS short pulses have been supported by...
by Clinical Neuropsychologist | Tuesday, January 14, 2025 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Rong Xu | January 14, 2025 Wiley: Alzheimer’s &...
by Clinical Neuropsychologist | Tuesday, January 14, 2025 | Dementia
Abstract Limbic predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is highly prevalent in late life and a common co-pathology with Alzheimer’s disease neuropathologic change (ADNC). LATE-NC is a slowly progressive, amnestic clinical...
by Clinical Neuropsychologist | Tuesday, January 14, 2025 | Dementia
Abstract INTRODUCTION This study describes the implementation outcomes and evaluation of DEM-SKY, a community-based dementia screening program developed in rural Kenya with the support of community health care workers (CHWs). METHODS DEM-SKY was delivered to 3546...
by Clinical Neuropsychologist | Tuesday, January 14, 2025 | Dementia
Abstract INTRODUCTION Using an Asian cohort with high prevalence of concomitant cerebrovascular disease (CeVD), we evaluated the performance of a plasma immunoassay for tau phosphorylated at threonine 217 (p-tau217) in detecting amyloid beta positivity (Aβ+) on...
